ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,655Medicare Part D Prescriptions Filled, Including Refills

Rank: 113 out of 3001

$957K Total Retail Price of All Prescriptions

Rank: 121 out of 3001

517 Patients Receiving at Least One Drug in Part D
93%Patients 65 Years and Older
42% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Ohio
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 517 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

9% of this provider’s 517 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

1% of this provider’s 14,966 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$57 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

32 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Ohio
SIMVASTATIN 798 758 1 1
LEVOTHYROXINE SODIUM 530 481 2 3
LISINOPRIL 506 476 3 2
POLYETHYLENE GLYCOL 3350 486 395 4 55
FUROSEMIDE 444 438 5 6
OMEPRAZOLE 404 343 6 4
AMLODIPINE BESYLATE 367 338 7 5
METOPROLOL TARTRATE 362 327 8 8
ATORVASTATIN CALCIUM 297 260 9 11
METFORMIN HCL ER 296 240 10 51
WARFARIN SODIUM 259 253 11 12
PRAVASTATIN SODIUM 258 235 12 13
BISOPROLOL-HYDROCHLOROTHIAZIDE 257 242 13 111
SERTRALINE HCL 255 238 14 20
GABAPENTIN 251 232 15 14
METOPROLOL SUCCINATE 247 245 16 19
LISINOPRIL-HYDROCHLOROTHIAZIDE 244 209 17 22
TRAMADOL HCL 225 200 18 17
POTASSIUM CHLORIDE 206 166 19 15
PREDNISONE 200 197 20 39
VENLAFAXINE HCL 191 144 21 171
CLOPIDOGREL 186 184 22 28
LOSARTAN POTASSIUM 178 177 23 21
LANTUS 172 127 24 47
ALLOPURINOL 168 158 25 35
PLAVIX 149 149 26 46
HYDROCODONE-ACETAMINOPHEN 147 140 S3 27 7
ADVAIR DISKUS 137 136 28 58
CITALOPRAM HBR 135 134 29 16
CRESTOR 134 120 30 33
CARVEDILOL 133 125 31 25
TAMSULOSIN HCL 130 128 32 29
AZITHROMYCIN 120 112 33 36
CYMBALTA 116 70 34 53
DILTIAZEM 24HR CD 114 106 35 124
EXELON 108 96 36 108
ALBUTEROL SULFATE 106 99 37 99
HYDROCHLOROTHIAZIDE 106 101 37 10
GLIMEPIRIDE 101 80 39 31
KLOR-CON M20 100 86 40 52
ZOLPIDEM TARTRATE 100 94 40 24
FLUDROCORTISONE ACETATE 99 91 42 402
FINASTERIDE 98 84 43 92
DIGOXIN 96 95 44 65
NOVOLOG 96 71 44 94
SPIRIVA 93 77 46 57
SPIRONOLACTONE 91 79 47 75
DOXYCYCLINE HYCLATE 88 50 48 105
VENLAFAXINE HCL ER 85 85 49 103
INSULIN SYRINGE 84 55 50 162
NEXIUM 81 72 51 23
IPRATROPIUM BROMIDE 80 75 52 183
DOXAZOSIN MESYLATE 79 66 53 90
VOLTAREN 79 75 53 272
DONEPEZIL HCL 76 76 55 27
OXYBUTYNIN CHLORIDE 74 74 56 120
CARBIDOPA-LEVODOPA 73 73 57 97
CLONIDINE HCL 73 47 57 64
DIVALPROEX SODIUM 72 69 59 70
MIRTAZAPINE 71 71 60 44
LYRICA 69 69 61 87
PANTOPRAZOLE SODIUM 69 68 61 43
GLYBURIDE 68 62 R 63 62
LIDODERM 67 50 64 122
METFORMIN HCL 65 54 65 9
ROPINIROLE HCL 65 53 65 88
RISPERIDONE 64 51 67 63
QUETIAPINE FUMARATE 62 58 68 66
ALENDRONATE SODIUM 62 62 68 26
SULFAMETHOXAZOLE-TRIMETHOPRIM 62 57 68 77
ACETYLCYSTEINE 59 59 71 529
LABETALOL HCL 58 37 72 189
ABILIFY 58 49 72 144
DILTIAZEM 24HR ER 56 56 74 131
MIDODRINE HCL 56 44 74 305
FAMOTIDINE 56 40 74 68
CELEBREX 56 40 74 89
PROAIR HFA 55 27 78 30
NOVOLIN N 55 16 78 231
OLANZAPINE 54 41 80 106
VITAMIN D2 53 53 81 205
TRIAMTERENE-HCTZ 52 52 82 48
LOSARTAN-HYDROCHLOROTHIAZIDE 50 50 83 49
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 6, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.